Vichin Puri, MD
Transplant Surgery · Dallas, TXNPI 1003060211
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for transplant surgery clinicians in TX, where the typical reported total is $2,154.
Across 78 payments — averaging $27.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$381
- Intercept Pharmaceuticals, Inc.$285
- Histosonics, Inc.$279
- AbbVie$240
- Gilead$187
- Stryker$171
- plus $588 from 14 others
What the payments were for
- Food & beverage$2,132100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 24 | $381 |
| Intercept Pharmaceuticals, Inc. | 15 | $285 |
| Histosonics, Inc. | 2 | $279 |
| AbbVie | 11 | $240 |
| Gilead | 10 | $187 |
| Stryker | 1 | $171 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $153 |
| Eurofins Viracor, LLC | 1 | $129 |
| Hemosonics LLC | 1 | $66 |
| Eisai Inc. | 2 | $46 |
| Fujifilm Healthcare Americas Corporation | 1 | $28 |
| Madrigal Pharmaceuticals | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Dynavax Technologies Corporation | 1 | $19 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $18 |
| Eton Pharmaceuticals, Inc. | 1 | $17 |
| Shire North American Group Inc | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPY-PHI SYSTEM$171
- Phasix Mesh$153
How this compares
$2,132 in reported general payments places this provider in the 45th percentile of 70 transplant surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant surgery in Dallas
- Goran KlintmalmDallas$88K
- Alejandro MejiaDallas$20K
- Richard RuizDallas$16K
- Christie GoodenDallas$8K
- Steven HanishDallas$7K
- Lori KautzmanDallas$7K
- Jason SchwartzDallas$5K
- Tiffany AnthonyDallas$5K
- Anji WallDallas$4K
- Gregory McKennaDallas$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.